Dissolution Testing Protocol

Dissolution testing protocols establish standardised procedures for measuring pharmaceutical active ingredient release rates from solid dosage forms, providing critical quality control assays and bioavailability indicators. USP apparatus employing paddles, baskets, and flow-through designs simulate gastrointestinal conditions including pH gradients, fluid composition, and mechanical mixing. Specifications define acceptable dissolution profiles establishing minimum drug release percentages at defined timepoints. Comparative dissolution testing evaluates bioequivalence supporting generic drug approvals and post-approval changes.

Instrument calibration, apparatus suitability, and medium preparation require strict standardisation ensuring reproducibility. Supersaturation effects and precipitation phenomena in low-pH media complicate testing for weakly acidic or poorly soluble drugs. Modified release formulations require extended testing timeframes capturing delayed and extended release profiles. Biorelevant media incorporating physiological components including bile salts and phospholipids enhance predictive value for poorly soluble drugs. Dissolution correlations with in vivo bioavailability strengthen formulation development decisions and support regulatory submissions.